Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond Standard Culture: Diagnostic Value of Ureaplasma and Chlamydia in Women with UTI Symptoms.

Medeniyet medical journal·2026
Same author

Comparative evaluation of a folkloric plant extract in a rat partial nephrectomy model.

Acta cirurgica brasileira·2026
Same author

The impact of microscopic extrathyroidal extension on the prognosis of medullary thyroid carcinoma: A multicenter cohort study.

Endocrinologia, diabetes y nutricion·2025
Same author

The effect of HbA1C variability on the development and progression of diabetic nephropathy.

Frontiers in clinical diabetes and healthcare·2025
Same author

Which Nutritional Scoring System Best Predicts Transplant Outcomes in Allogeneic Stem Cell Recipients? A Comparison of Nutritional Risk Index, Prognostic Nutritional Index, and Controlling Nutritional Status.

Sisli Etfal Hastanesi tip bulteni·2025
Same author

Correction: Reverse placement of a double J ureteral stent improves lower urinary tract symptoms.

BMC urology·2025
Same journal

Regional differences in corpora cavernosa morphology exist along the proximal to distal axis of the penis in adult Sprague Dawley rats.

The journal of sexual medicine·2026
Same journal

Floppy glans syndrome revisited: a modern classification and mechanistic framework for distal penile support deficiency following penile prosthesis placement.

The journal of sexual medicine·2026
Same journal

Erectogenic potential of alpha-1 blockers: is it really true? Systematic review of case reports.

The journal of sexual medicine·2026
Same journal

Development and reliability assessment of a masturbation-adapted sexual health inventory for men to assess postoperative sexual recovery after robot-assisted radical prostatectomy.

The journal of sexual medicine·2026
Same journal

Clinical assessment of sexual function in transwomen.

The journal of sexual medicine·2026
Same journal

Vagina-sparing metoidioplasty: technique and outcomes.

The journal of sexual medicine·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

Hyperthyroidism: a risk factor for female sexual dysfunction.

Gokhan Atis1, Ayhan Dalkilinc, Yuksel Altuntas

  • 1Department of Urology, Goztepe Training and Research Hospital, Istanbul, Turkey. gokhanatis@hotmail.com

The Journal of Sexual Medicine
|June 18, 2011
PubMed
Summary
This summary is machine-generated.

Women with hyperthyroidism experience significant sexual dysfunction, impacting desire, arousal, and satisfaction. Increased depression, SHBG, and decreased free testosterone levels are linked to this dysfunction.

More Related Videos

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function
04:05

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function

Published on: October 6, 2023

Related Experiment Videos

Last Updated: May 31, 2026

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:24

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function
04:05

A Versatile, Behavioral Method to Investigate Thyroid Hormone Effects on Cerebellar Function

Published on: October 6, 2023

Area of Science:

  • Endocrinology
  • Sexual Medicine
  • Women's Health

Background:

  • Hyperthyroidism is a prevalent hormonal disorder in women.
  • It is associated with a potential risk of female sexual dysfunction (FSD).

Purpose of the Study:

  • To investigate and assess sexual function in women diagnosed with hyperthyroidism.
  • To identify potential physiological and psychological factors contributing to FSD in this population.

Main Methods:

  • A comparative study involving 40 women with hyperthyroidism and 40 age-matched healthy controls.
  • Utilized the Female Sexual Function Index (FSFI) for sexual assessment and the Beck Depression Inventory (BDI) for psychiatric evaluation.
  • Measured serum levels of thyroid hormones (TSH, T3, T4), sex hormones (SHBG, testosterone, estradiol), and prolactin.

Main Results:

  • Women with hyperthyroidism reported significantly lower overall FSFI scores compared to controls (P < 0.0001).
  • All domains of sexual function, including desire, arousal, lubrication, orgasm, satisfaction, and pain, were significantly impaired in the hyperthyroid group.
  • Hyperthyroid patients exhibited higher BDI scores (P < 0.0001), elevated SHBG (P < 0.0001), and lower free testosterone (fT) levels (P < 0.0001).
  • FSFI scores negatively correlated with SHBG, free thyroid hormones, and BDI scores, while positively correlating with total testosterone and TSH levels.

Conclusions:

  • Clinical hyperthyroidism is significantly associated with female sexual dysfunction.
  • Depressive symptoms, elevated sex hormone-binding globulin (SHBG), and reduced free testosterone (fT) levels are key factors linked to FSD in women with hyperthyroidism.